Persistent symptoms and quality of life after novel coronavirus infection (COVID-19)
N. Lyubavina (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), M. Milyutina (Nizhny Novgorod, Russian Federation), E. Makarova (Nizhny Novgorod, Russian Federation), E. Galova (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), E. Nekaeva (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), I. Polyakova (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), N. Menkov (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), A. Egorskaya (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation)
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Session: Clinical features and challenges of COVID-19
Session type: E-poster
Number: 296
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Lyubavina (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), M. Milyutina (Nizhny Novgorod, Russian Federation), E. Makarova (Nizhny Novgorod, Russian Federation), E. Galova (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), E. Nekaeva (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), I. Polyakova (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), N. Menkov (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), A. Egorskaya (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation). Persistent symptoms and quality of life after novel coronavirus infection (COVID-19). 296
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Impact of the novel coronavirus (COVID-19) pandemic on sleep Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021
Influenza vaccination in asthmatic children: effects on quality of life and symptoms Source: Eur Respir J 2004; 24: 925-931 Year: 2004
The effect of the novel type coronavirus infection on the mental health of the patients Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021
Diffusion ability of the lungs in the assessment of respiratory function in patients who have undergone the new coronavirus infection (COVID-19) Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
A much shorter core outcome set (COS) for measuring the health-related quality of life (HRQOL) effects of common acute respiratory symptoms Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021
Change in respiratory symptoms and health related quality of life in a community study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005
Chronic cough, quality of life and the partner Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008
Relations among questionnaire and laboratory measures of rhinovirus infection Source: Eur Respir J 2006; 28: 358-361 Year: 2006
Respiratory impact and quality of life in patients with common variable immunodeficiency receiving subcutaneous IgG replacement therapy Source: Annual Congress 2007 - Diagnostic tests and treatment in non cystic fibrosis bronchiectasis Year: 2007
Pattern of self-reported (cough focus) symptoms across several respiratory virus- human challenge studies Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018
Impact of respiratory syncytial virus infection and palivizumab on severe acute lower respiratory infection during the first 6 months of life in a cohort of Colombian infants. Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018
Serial viral infections in infants with recurrent respiratory illnesses Source: Eur Respir J 2008; 32: 314-320 Year: 2008
Respiratory syncytial virus in adults: relationships between viral load, symptoms and lung function in an experimental infection model Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections Year: 2008
Sporadic coronavirus and human metapneumovirus lower respiratory tract infection in adults: comparison of chest CT findings and correlation with clinical outcomes Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020
Historical perspective: other human coronavirus infectious diseases, SARS and MERS Source: Eur Respir Monogr 2021; 94: 28-38 Year: 2021
Lower respiratory tract illness due to rhinovirus in the first year of life Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year Source: Eur Respir J 2010; 35: 1022-1030 Year: 2010
Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020
Determining clinically important change in health-related quality of life in survivors of acute respiratory distress syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 70s Year: 2003
Psychological impact of chronic cough on quality of life Source: Eur Respir J 2004; 24: Suppl. 48, 47s Year: 2004